Meiji Seika Of Japan Launches Larger Dose Of Depromel Antidepressant
This article was originally published in PharmAsia News
Executive Summary
Japan's Meiji Seika Kaisha launched a larger-dose version of its Depromel (fluvoxamine maleate) antidepressant aimed at a greater share of the Japanese market. The newly marketed 75mg version allows patients to get the treatment by taking fewer pills, a convenience Meiji Seika plans to leverage. The company already has been marketing 50mg and 25mg versions of the drug. The drug, in all sizes, is marketed by Astellas Pharma under the brand name Luvox. (Click here for more - a subscription may be required